3-(2-羟苯基)丙酸甲酯 | 20349-89-7

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 3-(2-羟苯基)丙酸甲酯
• 中文别名: 3-(2-羟基苯基)丙酸甲酯
• 英文名称: methyl 3-(2-hydroxyphenyl)propionate
• 英文别名: methyl 3-(2-hydroxyphenyl)propanoate；3-(2-hydroxy-phenyl)propanoic acid methyl ester；β-(2-Hydroxy-phenyl)-propionsaeure-methylester；2-hydroxybenzenepropanoic acid methyl ester
• CAS: 20349-89-7
• 化学式: C₁₀H₁₂O₃
• mdl: MFCD00067757
• 分子量: 180.203
• InChiKey: YHXYRISRGHSPNV-UHFFFAOYSA-N

物化性质

• 熔点：
  40-42°C
• 沸点：
  280.2±15.0 °C(Predicted)
• 密度：
  1.146±0.06 g/cm3(Predicted)
• 稳定性/保质期：

  如果按照规定使用和储存，则不会分解。避免接触氧化物。

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2918290000
• WGK Germany：
  3
• 储存条件：
  保持贮藏器密封，并将其放入一个紧密封装的容器中。应存放在阴凉、干燥处。

SDS

Name:	Methyl 3-(2-hydroxyphenyl)propanoate 95%+ Material Safety Data Sheet
Synonym:
CAS:	20349-89-7

Section 1 - Chemical Product MSDS Name:Methyl 3-(2-hydroxyphenyl)propanoate 95%+ Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
20349-89-7	Methyl 3-(2-hydroxyphenyl)propanoate	95%+	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 20349-89-7: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 40 - 42 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H12O3
Molecular Weight: 180.2

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 20349-89-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Methyl 3-(2-hydroxyphenyl)propanoate - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 20349-89-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 20349-89-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 20349-89-7 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-(2-羟苯基)丙酸甲酯 在 氢氧化钾 、 sodium hydroxide 、 水 作用下， 以 四氢呋喃 、 甲醇 、 水 为溶剂， 反应 4.0h， 生成 3-(2'-(Benzyloxy)phenyl)propionic Acid
  参考文献：
  名称：

  Synthesis and physicochemical assessment of novel 2-substituted 3-hydroxypyridin-4-ones, novel iron chelators

  摘要：

  标题：摘要 新型含三齿配体的3-羟基吡啶-4-酮被合成，并对其物理化学性质进行了表征，包括电离常数和与Fe(III)的化学计量滴定。目前急需口服活性铁螯合剂，以潜在治疗地中海贫血。原则上，三齿配体可能比双齿分子更具动力学稳定性，但迄今尚未找到令人满意的分子。通过与六齿配体EDTA竞争评估了Fe(III)的稳定常数。在所有情况下，均未发现三齿铁螯合模式的证据；相反，配体表现为双齿羟基吡啶酮。因此，它们与更简单的烷基羟基吡啶酮相比并无优势。

  DOI：

  10.1211/0022357021778592
• 作为产物：
  描述：

  Methyl α-nitro-β-phenylpropionate 在 三氟甲磺酸 作用下， 以 氯仿 、 甲苯 为溶剂， 反应 2.58h， 生成 3-(2-羟苯基)丙酸甲酯
  参考文献：
  名称：

  苯环上载有各种取代基的邻醌甲基苯胺的生成与应用

  摘要：

  邻醌甲基化物（o -QMs）是高反应性，寿命短的中间体，具有潜在的合成适用性。但是，关于带有吸电子基团的o -QM的生成的研究很少。本文中，我们介绍了一种从新的前体4 H -1,2-苯并恶嗪2生成o- QM（特别是被亲电取代基取代的邻QM）的通用方法。我们还系统地研究了O - QM与各种亲双烯体（如乙烯基醚，烯胺和亚胺）的Diels-Alder反应。反应为取代的苯并二氢吡喃，苯酚和3,4-二氢-2 H-苯并[e ] [1,3]恶嗪（3,4-二氢-1,3-苯并恶嗪）。此外，我们将新方法应用于某些天然产物的衍生化。

  DOI：

  10.1002/adsc.200600508

文献信息

• Visible Light-Induced Borylation of C–O, C–N, and C–X Bonds
  作者：Shengfei Jin、Hang. T. Dang、Graham C. Haug、Ru He、Viet D. Nguyen、Vu T. Nguyen、Hadi D. Arman、Kirk S. Schanze、Oleg V. Larionov

  DOI：10.1021/jacs.9b12519

  日期：2020.1.22

  photocatalytic borylation method that can effect borylation of a wide range of substrates, including strong C‒O bonds, remains elusive. Herein, we report a general, metal-free visible light-induced photocatalytic borylation platform that enables borylation of electron rich derivatives of phenols and anilines, chloroarenes, as well as other haloarenes. The reac-tion exhibits excellent functional group

  硼酸是中心重要的功能基序和合成前体。可见光诱导的硼酸化可以提供结构多样化的硼酸盐，但一种广泛有效的光催化硼酸化方法可以影响包括强 C-O 键在内的多种底物的硼化，仍然难以实现。在此，我们报告了一种通用的、无金属的可见光诱导光催化硼化平台，该平台能够对苯酚和苯胺、氯芳烃以及其他卤代芳烃的富电子衍生物进行硼化。该反应表现出优异的官能团耐受性，正如一系列结构复杂底物的硼化反应所证明的那样。值得注意的是，该反应是由吩噻嗪催化的，这是一种简单的有机光催化剂，MW< 200通过质子耦合电子转移机制介导了以前无法实现的可见光诱导的苯酚衍生物单电子还原，还原电位为~-3 V vs SCE。机理研究指出了光催化剂-碱相互作用的关键作用。
• Second-GenerationcycloSal-d4TMP Pronucleotides Bearing Esterase-Cleavable Sites — The “Trapping” Concept
  作者：Chris Meier、Christian Ducho、Henning Jessen、Dalibor Vukadinović-Tenter、Jan Balzarini

  DOI：10.1002/ejoc.200500490

  日期：2006.1

  An extension of the cycloSal-pronucleotide approach is presented. Attachment of an enzyme-cleavable ester/acylal group to the cycloSal-d4TMP triesters should allow these compounds to be trapped intracellularly after cleavage. The ester/acylal groups were introduced in the 3- or 5-position of the cycloSal ring system, and surprising differences were observed in hydrolysis studies in CEM cell extracts

  介绍了 cycloSal-核苷酸方法的扩展。将酶可裂解的酯/酰基基团连接到 cycloSal-d4TMP 三酯上应该允许这些化合物在裂解后被捕获在细胞内。在环Sal环系统的3-或5-位引入酯/酰基基团，并且在CEM细胞提取物的水解研究中观察到关于酯/酰基部分的惊人差异。虽然乙酰基酯和乙酰丙酸酯很容易裂解，但 cycloSal-d4TMP 酸的烷基酯证明对酶促裂解具有抗性。相比之下，AM-、POM- 和 POC-酰基在提取物中迅速裂解，产生 cycloSal-d4TMP 酸。还介绍了化合物对 HIV 的抗病毒活性。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2006)
• Neurotrophin production secretion promoting agent
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US06605629B1

  公开（公告）日：2003-08-12

  A neurotrophin production/secretion promoting agent which comprises an azole derivative of the formula: wherein R1 represents a halogen atom, a heterocyclic group which may optionally be substituted, a hydroxy group which may optionally be substituted, a thiol group which may optionally be substituted, or an amino group which may optionally be substituted; A represents an acyl group which may optionally be substituted, a heterocyclic group which may optionally be substituted, a hydroxy group which may optionally be substituted, or a carboxyl group which may optionally be esterified or amidated; B represents an aromatic group which may optionally be substituted; X represents oxygen atom, sulfur atom, or nitrogen atom which may optionally be substituted; and Y represents a divalent hydrocarbon group or heterocyclic group, or a salt thereof; which is useful as an agent for preventing or treating neuropathy.

  一种促进神经营养素产生/分泌的剂，该剂包括公式的唑衍生物： 其中R1代表卤素原子，可选地被取代的杂环族，可选地被取代的羟基，可选地被取代的巯基，或可选地被取代的氨基；A代表可选地被取代的酰基，可选地被取代的杂环族，可选地被取代的羟基，或可选地被酯化或酰胺化的羧基；B代表可选地被取代的芳香族；X代表氧原子，硫原子或可选地被取代的氮原子；Y代表二价烃基或杂环族，或其盐；该剂用作预防或治疗神经病的剂。
• [EN] ARYLOXAZOLIDINONE ANTIBIOTIC COMPOUNDS<br/>[FR] COMPOSÉS ANTIBIOTIQUES ARYLOXAZOLIDINONE
  申请人：IDORSIA PHARMACEUTICALS LTD

  公开号：WO2018149960A1

  公开（公告）日：2018-08-23

  The invention relates to aryloxazolidinone compounds of formula I: wherein Y represents hydrogen or certain chemical groups. These compounds are useful antimicrobial agents effective against a variety of pathogens including inter alia Gram -negative aerobic and anaerobic bacteria.

  这项发明涉及式I的芳基噁唑啉酮化合物：其中Y代表氢或某些化学基团。这些化合物是有效的抗微生物药剂，可对抗包括革兰氏阴性需氧和厌氧细菌在内的各种病原体。
• [EN] WDR5-MYC INHIBITORS<br/>[FR] INHIBITEURS DE WDR5-MYC
  申请人：UNIV VANDERBILT

  公开号：WO2021021951A1

  公开（公告）日：2021-02-04

  Substituted N-phenyl sulfonamide compounds inhibit WDR5-MYC interactions, and the compounds and their pharmaceutical compositions are useful for treating disorders and conditions in a subject, such as cancer cell proliferation.

  取代的N-苯基磺酰胺化合物可以抑制WDR5-MYC相互作用，这些化合物及其药物组合物可用于治疗受试者中的疾病和状况，如癌细胞增殖。